Click here to read more Quest articles. print | Print this page
From Winter 2013 Quest

The Large Urology Group Practice Association (LUGPA) released its prostate cancer screening guidelines in response to the recent PSA controversy, saying that data clearly demonstrates that doctors are detecting prostate cancer earlier and thus saving lives.

The LUGPA’s position on PSA screening is:

“As the clinicians whose specialty is dedicated to the appropriate diagnosis and treatment of prostate cancer, urologists must remain steadfast in protecting the rights of men and their caregivers to appropriately access PSA testing.”

Dr. Deepak A. Kapoor, president of LUGPA

LUGPA is an organization advocating for integrated and coordinated urological care with more than 2,000 physician experts across the U.S. The association represents 121 large urology group practices in the United States, with more than 2,000 physicians who make up more than 20% of the nation’s practicing urologists.

Close this window